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Interstitial Cells and Bladder Pathophysiology—Passive
Bystanders or Active Participants?INTERSTITIAL cells (ICs) in the bladder have been inves-
tigated for more than a decade by many independent
groups throughout the world. These efforts have pro-
vided compelling evidence that the bladder wall con-
tains subpopulations of ICs in the mucosal and detru-
sor regions that are structurally associated with
urothelial cells, smooth muscle cells and nerves, with
some populations comprising interconnected net-
works.1 ICs have been visualized in human and ani-
mal tissues using markers such as vimentin or KIT
antibodies, and have been characterized ultrastructur-
ally with transmission electron microscopy.
Physiological studies of IC subtypes in the bladder
concur that these novel cells may contribute to the
complex cellular signalingwithin the bladderwall that
underpins normal bladder function. Davidson andMc-
Closkey hypothesized that ICs may form a functional
conduit for the transmission of signals from the
urothelium to other cells within the bladder wall.2
Moreover others have suggested a role for ICs in the
sensory response to stretch during filling.3 ICs have
been broadly considered to act by pacemaking or mod-
ulating detrusor smooth muscle spontaneous activity
within the normal bladder.1 In support of this idea
mucosal and detrusor ICs exhibit spontaneous electri-
cal and Ca2 signaling profiles whichmay be commen-
surate with pacemaking. However, there is currently
insufficient direct evidence that ICs modulate the ac-
tivity of normal detrusor smooth muscle.
The role of ICs in the bladder may actually be
more apparent in pathophysiological conditions
such as obstructed bladder, neurogenic bladder or
painful bladder syndrome/interstitial cystitis, all
of which are associated with detrusor overactivity.
Increased numbers of ICs have been shown in
samples of overactive human bladder,4 and aug-
mented connexin 43 labeling associated with muco-
sal ICs has been reported in human5 and rat neuro-
genic bladders.6 Kubota et al reported a marked
increase in suburothelial and subserosal IC popula-
tions in guinea pig obstructed bladder.7 Their find-
ings were consistent with the recent work of Grol et
al in this issue of The Journal (page 1959), who
further demonstrated M3 muscarinic receptor ex-
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Open access under CC BY license.pression on bladder ICs. A study of mucosal (sub-
urothelial) ICs in bladder samples from patients
with neurogenic detrusor overactivity and painful
bladder syndrome demonstrated ultrastructural
and morphological changes resulting in transforma-
tion to a more fibroblast-like phenotype.8
Observations of enhanced IC numbers in bladders
from patients or animal models with an overactive
phenotype raise the question of whether these 2
phenomena may be linked. It is not yet clear
whether defects in IC subpopulations contribute to
the cause of bladder dysfunction or whether they
occur as a consequence of bladder wall remodeling,
eg hypertrophy, which typically accompanies neuro-
genic or obstructed bladder. In vitro tension record-
ings from overactive human bladder tissues with
enhanced numbers of ICs showed increased contrac-
tility which was more sensitive to imatinib mesylate
(Gleevec®, which targets KIT-positive ICs) than the
activity of normal tissues.4 Gleevec was also re-
ported to reduce spontaneous contractions of blad-
ders from spinal cord injured rats in contrast to
controls, where there was little effect.9 Interestingly
the opposite situation has been found in the under-
active bladder phenotype seen in patients with
megacystis-microcolon intestinal hypoperistalsis
syndrome in which the typical unobstructed, dis-
tended bladder lacked ICs compared with control
tissues.10
The current literature consistently indicates that
changes in the numbers of IC subpopulations are as-
sociated with dysfunctional phenotypes, giving sup-
port to the notion that ICs may be responsible for
bladder pathophysiology and, therefore, may present
novel therapeutic targets for the treatment of dysfunc-
tional bladder. More research is needed in this area to
address the caveats associated with considering ICs as
potential treatment options. Appropriately powered
studies on IC expression and activity in patient tissues
matched with clinical urodynamic assessment and
evaluation of reported symptoms are not yet available.
There are also limitations in translating basic re-
search findings from animal models to patient symp-
toms. The apparent correlation between bladder dys-
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fully account for aberrant bladder activity, which has
other credible explanations unrelated to ICs such as
smooth muscle hypertrophy, enhanced coupling be-
tween smooth muscle cells, connective tissue remodel-
ing, changes in afferent signaling or altered release of
factors from the urothelium.
In summary, we currently understand ICs as
modulators of smooth muscle activity in the normal
bladder by integrating and communicating informa-
tion from urothelial cells, smooth muscle cells,
nerves and microvessels. Their role may be rela-
tively minor, acting as passive bystanders until
stimulated by changes in the bladder microenviron-
ment to modify the activity of neighboring cells in
response. The function of these intriguing cells
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